Clinical Characteristics and Outcome of Patients with EZH2- Mutant Myelodysplastic Syndromes

被引：0
|
作者：
Ball, Somedeb [1 ]
Aguirre, Luis E. E. [1 ]
Jain, Akriti G. [1 ]
Hussaini, Mohammad O. [2 ]
Al Ali, Najla [3 ]
Tinsley-Vance, Sara Marie [1 ]
Chan, Onyee [4 ]
Kuykendall, Andrew T. [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
Sallman, David A. [5 ]
Padron, Eric [1 ]
Komrokji, Rami S. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematopathol & Lab Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[4] Dept Malignant Hematol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1531
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes
    Carella, Angelo M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (06) : 463 - 463
  • [32] GERIATRIC ASSESSMENT DEFINES IMPAIRMENTS AND CLINICAL OUTCOME IN MYELODYSPLASTIC SYNDROMES
    Stauder, R.
    Spross, J. M.
    Augschoell, J.
    LEUKEMIA RESEARCH, 2015, 39 : S65 - S65
  • [33] Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
    Nikoloski, Gorica
    Langemeijer, Saskia M. C.
    Kuiper, Roland P.
    Knops, Ruth
    Massop, Marion
    Tonnissen, Evelyn R. L. T. M.
    van der Heijden, Adrian
    Scheele, Theresia N.
    Vandenberghe, Peter
    de Witte, Theo
    van der Reijden, Bert A.
    Jansen, Joop H.
    NATURE GENETICS, 2010, 42 (08) : 665 - 667
  • [34] Clinical Characteristics and Mutational Profile of Patients With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
    Villarreal, Patricia
    Castro, Maria
    Asinari, Mariana
    Ricchi, Brenda
    Jauk, Federico
    Perusini, Agustina
    Arbelbide, Jorge
    Basquiera, Ana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S307 - S307
  • [35] Biologic characteristics of patients with hypocellular myelodysplastic syndromes.
    Goyal, R
    Qawi, H
    Ali, SI
    Dar, S
    Mundle, S
    Ahmed, B
    Quadri, M
    Naseer, OB
    Andrews, C
    Shetty, V
    Mativi, B
    Altampallam, K
    Lisak, L
    Loew, J
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Raza, A
    BLOOD, 1998, 92 (10) : 629A - 629A
  • [36] Treatment and outcome of 23 paediatric patients with myelodysplastic syndromes (MDS)
    Polychronopoulou, S
    Panagiotou, JP
    Papadakis, V
    Parcharidou, A
    Psiachou, H
    Mavrou, A
    Haidas, S
    LEUKEMIA, 2000, 14 (05) : 969 - 969
  • [37] ANALYSIS OF OUTCOME OF MARROW TRANSPLANTATION IN 54 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    BARRALL, JL
    SHULMAN, HM
    STORB, RF
    THOMAS, ED
    APPELBAUM, FR
    CLINICAL RESEARCH, 1989, 37 (01): : A222 - A222
  • [38] Intensive chemotherapy and long term outcome in patients with myelodysplastic syndromes
    Zadrozny, N.
    Schuler, E.
    Strupp, C.
    Hildebrandt, B.
    Kuendgen, A.
    Kondakci, M.
    Haas, R.
    Kobbe, G.
    Germing, U.
    Oncology Research and Treatment, 2015, 38 : 69 - 69
  • [39] Clinical and biological characteristics of myelodysplastic syndromes with nulisomy Y by FISH
    GarciaIsidoro, M
    Tabernero, MD
    Najera, ML
    Garcia, JL
    Hernandez, JM
    Duran, A
    SanMiguel, JF
    Orfao, A
    HAEMATOLOGICA, 1997, 82 (05) : 537 - 541
  • [40] Clinical characteristics and outcome of patients with acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS) with abnormalities in the long arm of chromosome 3.
    Cortes, J
    Keating, M
    OBrien, S
    Kantarjian, H
    Freireich, EJ
    Estey, E
    BLOOD, 1996, 88 (10) : 3340 - 3340
12345